Connect
← Return to Webinar: What Women Need to Know about Ovarian Cancer
Event
Webinar: What Women Need to Know about Ovarian Cancer
Event Date: May 12, 2015 | 12:00pm - 1:00pm ET
Comment receiving replies
Recent Foundation One testing of a metastatic squamous cell carcinoma of the lung lobe showed BRCA1 and BRCA2 as VUS (varients of unknown significance), present but unknown as to their effects on the SCC. Is this evidence that I carry both gene alterations and should consider preventative treatment for Ovarian cancer?
Replies to "Recent Foundation One testing of a metastatic squamous cell carcinoma of the lung lobe showed BRCA1..."
Connect
Many types of tumors develop mutations in genes over time. Most often these mutations or alterations in tumors are not inherited. Encourage you to discuss results with your oncologist.